Risk factor
Negligible price volatility
Profitability factor
Greatly undervalued vs peers
About
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITD.
Target Price
The average target price of 2784.T is 2189 and suggests 9% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
Buy
Sell